check_circleStudy Completed

Pityriasis versicolor

Bayer Identifier:

Trial_0120

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
BAY H 4502 1% Solution: Efficacy and Tolerability in Patients with Pityriasis versicolor

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

N/A
  • -

  • -

Trial summary

Enrollment Goal
42
Trial Dates
January 1980 - January 1981
Phase
Phase 2
Could I Receive a placebo
N/A
Products
Mycospor/Canesten Extra (Bifonazole, BAYH4502)
Accepts Healthy Volunteer
N/A

Trial design

BAY H 4502 1% Solution: Efficacy and Tolerability in Comparison to a Placebo Solution in Patients with Pityriasis versicolor
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A